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The utility and safety of temporary pacing wires in postoperative
patients with congenital heart disease
Jose M. Moltedo, MD,a,d Geoffrey L. Rosenthal, MD,b Jeffrey Delaney, MD,c,d Dennis Mello, MD,d,f
and Christopher S. Snyder, MD,d,e Buenos Aires, Argentina, Cleveland, Ohio, Durham, NC,
New Haven and Hartford, Conn, and New Orleans, La
Arrhythmias constitute a common complication aftercardiovascular surgery (CVS) in pediatric patients.1-3Pacing wires are helpful in the differentiation andtreatment of supraventricular, ventricular, and sinus
tachycardia. The purpose of this study was to determine (1)
whether pacing wires are useful in the diagnosis and treatment of
early postoperative arrhythmias, (2) whether any factors exist to
predict patients who benefit from their placement, and (3) the
complications associated with their placement, use, or removal.
Clinical Summary
A single-center, institutional review board–approved, prospective
observational study was performed. Inclusion criteria were as
follows: patient age of less than 18 years and CVS between
September 2000 and March 2003. Exclusion criteria were a patent
ductus arteriosus ligation or coarctation of the aorta repair because
wires were not placed. Data collected included cardiopulmonary
bypass (CPB) and aortic crossclamp (AXC) times, pacing wire
placement and location, use of pacing wires, and complications.
Before chest tube removal and transfer from the intensive care
unit, wires were removed by a pediatric cardiology fellow.
The Student test and  analysis, along with simple and multiple
logistic regression analysis, were used to make comparisons.
A total of 209 patients met the inclusion criteria: 170 (81%)
having pacing wires, 159 (93.5%) having atrial and ventricular
wires, 10 (5.9%) having ventricular wires, and 1 having atrial
pacing wires. Wires were used in 59 (35%) patients: 33 for
diagnostic purposes, 11 for therapeutic purposes, and 15 for both
purposes.
Comparisons between group 1, those with pacing wires, and
group 2, those without pacing wires, found a significant difference
in CPB time (123.8 vs 46.1 minutes) and AXC time (59.5 vs 18.5
minutes,) P  .0001).
Splitting group 1 into those who used their pacing wires (group
1A) versus those who did not (group 1B), direct relationships were
found between longer AXC time (81.4 vs 47.9 minutes, P 
.0001) and CPB time (151.3 vs 109.1 minutes, P .0006). Further
analysis of group 1A, dividing it into those who used the wires for
therapeutic, diagnostic, or both therapeutic and diagnostic pur-
poses versus group 1B found that both AXC and CPB times
increased (Table 1).
For every 10-minute increase in AXC time, the odds of thera-
peutic use of the pacing wires increased by 27% (95% confidence
interval [CI], 16%–40%). For each 10-minute increase in CPB, the
odds of therapeutic use of the pacing wires increases by 13% (95%
CI, 7%–20%). When AXC and CPB times were entered into the
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TABLE 1. Comparisons between groups
AXC CPB Mg Ca
Pacing wires (n  170),
no pacing wires (n  59)
Group 1 59.5 123.8 1.5 4.78
Group 2 18.5 46.1 1.62 4.62
P value .0001 .0001 .004 NS
Use: group 1 patients
Group 1A (used; n  59),
Group 1B (unused; n  112)
Group 1A 81.4 151.3 1.49 4.81
Group 1B 47.9 109.1 1.51 4.77
P value .0001 .0006 NS NS
Therapeutic (n  28), diagnostic
(n  48), both (n  17)
Therapeutic 98.3 164.8 1.53 4.98
Group 1B/diagnostic 51.5 115.6 1.5 4.76
P value .0001 .0007 NS NS
Diagnostic 86 159 1.47 4.83
Group 1B/therapeutic 48.6 109.7 1.51 4.77
P value .0001 .0003 NS NS
Therapeutic 98.3 164.8 1.53 4.91
Diagnostic 65.7 139 1.46 4.74
P value .0213 NS NS NS
Aortic crossclamp and cardiopulmonary bypass times are measured in
minutes. Magnesium levels are measured in mg/dL, and ionized calcium
levels are measured in mg %. AXC, Aortic crossclamp; CPB, cardiopulmo-
nary bypass; Mg, magnesium; Ca, calcium; NS, not significant.
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model simultaneously, only AXC time was an important predictor
of therapeutic use of pacing wires.
In our group of patients, no complications related to the place-
ment, use, or removal of wires was noted. The 95% CI around the
estimate of complication rate is 0% to 1.2%. None of the patients
in whom wires were not placed experienced an arrhythmia. The
surgeons were able to predict with 100% accuracy the patients not
requiring pacing wires but only 26% (59/170) of those patients
who would.
Discussion
This study found the incidence of use of pacing wires to be equal
to 26% for post-CVS pediatric patients. Of those operations in
which pacing wires were placed, the percentage of use increased to
35%, with more than half (56%) for diagnostic purposes.
When analysis was performed to evaluate the need for pacing
wires (diagnostic, therapeutic, or both), 2 predictors fell out: length
of AXC and CPB time. When the group of patients with pacing
wires was further analyzed, therapeutic and diagnostic versus all
other, significantly longer AXC and CPB times were noted as
predictors. When comparisons were made between pacing wires
used for therapeutic and diagnostic purposes, the only difference
was in the AXC time (98.3 vs 65.7 minutes).
Although this study does not determine patients who require
pacing wires, it does provide some guidelines. Patients whose
AXC times, CPB times, or both are longer might benefit from
placing pacing wires at the time of CVS. With each 10-minute
increase in AXC or CPB time, a significant increase, 27% and
13%, occurred in the therapeutic use of pacing wires. These
findings, longer AXC and CPB times, might simply be variables of
the surgical complexity of the case. Despite anecdotal reports of
complications associated with pacing wires, no complications were
noted with the placement, use, or removal in this study.
Patients with longer CPB and AXC times associated with
more complicated surgical procedures have a significantly
higher chance of requiring pacing wires for their postoperative
management. In addition, their placement, use, and removal
appear to be safe.
References
1. Pfammatter JP, Bachmann DCG, Wagner BP, et al. Early postoperative
arrhythmias after open heart procedures in children with congenital
heart disease. Pediatr Crit Care Med. 2001;2:217-22.
2. Valsangiacomo E, Schmid ER, Schupbach RW, et al. Early postoper-
ative arrhythmias after cardiac surgery in children. Ann Thorac Surg.
2002;74:792-6.
3. Delaney J, Moltedo J, Dziura JD, et al. Early postoperative arrhythmias
after cardiac surgery in children. J Thorac Cardiovasc Surg. 2006;131:
1296-1300.
Hybrid approach as a bridging procedure to biventricular repair
for aortic hypoplasia with ventricular septal defect in
a 1720-g premature infant
Pedro Betrián Blasco, MD,a Josep Girona Comas, MD,a Arturo Gonçalves Estella, MD,b Queralt Ferrer Menduña, MD,a
María Concepción Céspedes Dominguez, MD,c Joan Balcells Ramirez, MD,d Begoña Manso García, MD,a
and Ferrán Gran Ipiña, MD,a Barcelona, Spain
Hypoplastic left heart syndrome varies from mitroaorticatresia and a diminutive left ventricle to milder formsof mitroaortic stenosis with a reasonable-sized leftventricle. Clinical SummaryA female infant with fetal diagnosis of aortic atresia was born at 34weeks of gestation weighing 1620 g. At birth, echocardiographywas carried out, showing a double-outlet right ventricle with great
vessels side to side and aorta on the right and a large subpulmonary
ventricular septal defect. The aorta was extremely hypoplastic,
with a minimal anterograde blood flow. The aortic arch was also
hypoplastic and filled with retrograde blood flow from the ductus.
The left ventricle and mitral valve were in normal values. Prosta-
glandin E1 infusion was started.
When she was 25 days old, weighing 1720 g, a median ster-
notomy was performed. First, pulmonary artery branches were
banded at their origin (polytetrafluoroethylene bands,* diameter of
2.8 mm). Next, two self-expandable stents (6  12/6  18 mm)
were placed through the main pulmonary artery puncture to cover
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